Another successful case of using JAK/STAT pathway inhibitors was demonstrated in patients with Hutchinson-Gilford progeria syndrome (HGPS), an incurable condition that affects fetuses through premature aging, causing early death [93]. This evidence concerns the gene SOAT1 and Hutchinson-Gilford progeria syndrome.